Inspections, Compliance, Enforcement, and Criminal Investigations
LSL Industries, Inc. - Close Out Letter 11/27/2012
| Public Health Service Food and Drug Administration |
| Chicago District 550 West Jackson Blvd., 15th Floor Chicago, Illinois 60661 Telephone: 312-353-5863 |
November 27, 2012
Mr. Ashok Luthra, Owner and President
LSL Industries, Inc.
5535 North Wolcott Ave.
Chicago, IL 60640
Dear Mr. Luthra:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter CHI-3-12 dated March 30, 2012. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Scott J. MacIntire
District Director





Department of Health and Human Services

